https://www.biotechsnap.com/ 2026-04-03T21:34:34+00:00 https://www.biotechsnap.com/subscribe 2026-04-03T21:34:34+00:00 https://www.biotechsnap.com/authors 2026-04-03T21:34:34+00:00 https://www.biotechsnap.com/p/daily-snap-17-november-2025 2025-11-17 1.0 https://www.biotechsnap.com/p/fibrogen-sec-data-manipulation-roxadustat 2025-09-12 1.0 https://www.biotechsnap.com/p/lilly-acquisition-adverum-gene-therapy 2025-10-27 1.0 https://www.biotechsnap.com/p/daily-snap-17-october-2025 2025-10-17 1.0 https://www.biotechsnap.com/p/gsk-buys-a-winrevair-rival-for-950m-breezebio-raises-60m-for-its-gene-delivery-technology 2026-02-26 1.0 https://www.biotechsnap.com/p/apollo-eczema-phase-2 2025-09-17 1.0 https://www.biotechsnap.com/p/generate-biomedicines-raises-400m-in-ipo-atrium-therapeutics-launches-with-270m-and-two-sirna-drugs 2026-03-02 1.0 https://www.biotechsnap.com/p/uniqure-huntington-gene-therapy-trial 2025-09-25 1.0 https://www.biotechsnap.com/p/prolium-launches-with-50m-to-advance-its-t-cell-engagers-boehringer-walks-away-from-ose-parternship 2026-03-05 1.0 https://www.biotechsnap.com/p/viking-oral-glp1-failure 2025-08-20 1.0 https://www.biotechsnap.com/p/gsk-buys-a-food-allergy-biotech-for-2-2b-exciva-raises-51m-to-fight-alzheimer-s-agitation-symptoms 2026-01-21 1.0 https://www.biotechsnap.com/p/johnson-johnson-halda-acquisition 2025-11-18 1.0 https://www.biotechsnap.com/p/biontech-halts-late-stage-melanoma-vaccine 2025-10-22 1.0 https://www.biotechsnap.com/p/daily-snap-4-november-2025 2025-11-04 1.0 https://www.biotechsnap.com/p/sanofi-wayrilz-fda-approval-btk 2025-09-01 1.0 https://www.biotechsnap.com/p/daily-snap-6-august-2025 2025-08-06 1.0 https://www.biotechsnap.com/p/bridgebio-s-dwarfism-pill-delivers-standout-phase-3-data-the-first-approval-of-an-immune-checkpoint 2026-02-13 1.0 https://www.biotechsnap.com/p/serb-y-mabs-acquisition 2025-08-06 1.0 https://www.biotechsnap.com/p/merck-cidara-acquisition-long-acting-flu-drug 2025-11-17 1.0 https://www.biotechsnap.com/p/fda-huntington-gene-therapy-uniqure 2025-11-04 1.0 https://www.biotechsnap.com/p/aerska-launch-brain-barrier-gene-therapy 2025-10-02 1.0 https://www.biotechsnap.com/p/genmab-acquisition-merus 2025-09-30 1.0 https://www.biotechsnap.com/p/boston-biotech-industry-2025 2025-07-07 1.0 https://www.biotechsnap.com/p/bergenbio-merger-oncoinvent 2025-07-02 1.0 https://www.biotechsnap.com/p/vertex-s-kidney-disease-drug-posts-strong-phase-3-results-bms-s-protein-degrader-wins-trial 2026-03-11 1.0 https://www.biotechsnap.com/p/daily-snap-26-september-2025 2025-09-26 1.0 https://www.biotechsnap.com/p/biontech-bms-pumitamig-lung-cancer-bispecific 2025-09-09 1.0 https://www.biotechsnap.com/p/otsuka-s-first-fda-approved-anti-april-therapy-valneva-s-site-closure 2025-12-01 1.0 https://www.biotechsnap.com/p/daily-snap-14-august-2025 2025-08-14 1.0 https://www.biotechsnap.com/p/cd40-antibody-metastatic-tumors-trial 2025-08-15 1.0 https://www.biotechsnap.com/p/kailera-is-heading-for-an-ipo-after-raising-1-billion-privately-betting-public-market-cash-can-help 2026-03-31 1.0 https://www.biotechsnap.com/p/response-rdx-002-post-glp-1-drug 2025-08-14 1.0 https://www.biotechsnap.com/p/excellergy-fundraising-allergy-treatment 2025-10-14 1.0 https://www.biotechsnap.com/p/pinnacle-raises-89m-for-its-oral-peptide-drugs-beam-reports-positive-phase-1-2-trial-of-its-base-edi-0380 2026-03-30 1.0 https://www.biotechsnap.com/p/adcytherix-series-a-adc 2025-10-17 1.0 https://www.biotechsnap.com/p/fda-ultra-rare-custom-made-therapies-pathway 2025-11-14 1.0 https://www.biotechsnap.com/p/daily-snap-4-september-2025 2025-09-04 1.0 https://www.biotechsnap.com/p/ac-immune-s-promising-parkinson-s-vaccine-a-british-biotech-buys-a-us-company-for-pennies-per-share 2025-12-15 1.0 https://www.biotechsnap.com/p/astrazeneca-cincor-trial-baxdrostat 2025-07-15 1.0 https://www.biotechsnap.com/p/hair-loss-startup-pelage-fundraising 2025-10-16 1.0 https://www.biotechsnap.com/p/alnylam-and-tenaya-sign-1b-heart-disease-deal-atavistik-raises-160m-to-advance-rare-blood-disorders- 2026-03-09 1.0 https://www.biotechsnap.com/p/madrigal-signs-a-4-4b-deal-with-a-chinese-rnai-company-fda-refuses-to-file-moderna-s-vaccine 2026-02-12 1.0 https://www.biotechsnap.com/p/biontech-patent-dispute-curevac-gsk-pfizer 2025-08-11 1.0 https://www.biotechsnap.com/p/astrazeneca-hypertension-baxdrostat-phase-3 2025-10-08 1.0 https://www.biotechsnap.com/p/tubulis-antibody-drug-conjugate-response-rate 2025-10-21 1.0 https://www.biotechsnap.com/p/daily-snap-15-july-2025 2025-07-16 1.0 https://www.biotechsnap.com/p/gsk-tebipenem-oral-antibiotic-phase-3-win-uti 2025-10-22 1.0 https://www.biotechsnap.com/p/arthrosi-series-e-gout-drug 2025-10-09 1.0 https://www.biotechsnap.com/p/r1-therapeutics-raises-78m-for-its-kidney-disease-drug-cytomx-s-shares-surge-over-60-after-phase-1-r-d95c 2026-03-19 1.0 https://www.biotechsnap.com/p/china-star-market-biotech-ipo 2025-06-23 1.0 https://www.biotechsnap.com/p/daily-snap-21-october-2025 2025-10-21 1.0 https://www.biotechsnap.com/p/daily-snap-11-august-2025 2025-08-11 1.0 https://www.biotechsnap.com/p/daily-snap-28-october-2025 2025-10-28 1.0 https://www.biotechsnap.com/p/fda-drug-delays-omeros-neurizon 2025-08-18 1.0 https://www.biotechsnap.com/p/molecular-glue-kymera-gilead-sanofi-deal 2025-06-26 1.0 https://www.biotechsnap.com/p/aktis-starts-2026-with-a-bang-and-a-318m-ipo-backed-by-eli-lilly-aurora-radiates-with-a-bold-plan-to 2026-01-12 1.0 https://www.biotechsnap.com/p/daily-snap-31-october-2025 2025-11-03 1.0 https://www.biotechsnap.com/p/vor-bio-changes-its-priorities-novo-nordisk-foundation-injects-736m-in-european-biotech 2026-01-16 1.0 https://www.biotechsnap.com/p/daily-snap-27-october-2025 2025-10-27 1.0 https://www.biotechsnap.com/p/daily-snap-17-july-2025 2025-07-17 1.0 https://www.biotechsnap.com/p/daily-snap-23-october-2025 2025-10-23 1.0 https://www.biotechsnap.com/p/novartis-profound-partnership 2025-06-27 1.0 https://www.biotechsnap.com/p/corporate-vc-biotech-funding-2025 2025-11-03 1.0 https://www.biotechsnap.com/p/daily-snap-25-november-2025 2025-11-25 1.0 https://www.biotechsnap.com/p/daily-snap-9-october-2025 2025-10-09 1.0 https://www.biotechsnap.com/p/reunion-postpartum-depression-trial 2025-08-19 1.0 https://www.biotechsnap.com/p/daily-snap-9-september-2025 2025-09-09 1.0 https://www.biotechsnap.com/p/enodia-snaps-up-competitor-s-pipeline-for-127m-ultragenyx-aav-based-gene-therapy-strikes-a-win-in-ph 2026-03-13 1.0 https://www.biotechsnap.com/p/renasant-bio-launch-rare-kidney-disease 2025-07-11 1.0 https://www.biotechsnap.com/p/evommune-ipo-oral-drug-skin 2025-10-13 1.0 https://www.biotechsnap.com/p/china-biotech-glp-1-laekna-corxel-sciwind 2025-06-25 1.0 https://www.biotechsnap.com/p/boehringer-inks-a-1-05b-with-simcere-roche-shows-what-its-weight-loss-drug-can-do 2026-01-28 1.0 https://www.biotechsnap.com/p/lilly-ai-biotech-tunelab 2025-09-10 1.0 https://www.biotechsnap.com/p/daily-snap-29-september-2025 2025-09-29 1.0 https://www.biotechsnap.com/p/evommune-ipo 2025-11-07 1.0 https://www.biotechsnap.com/p/pfizer-metsera-obesity-acquisition 2025-09-23 1.0 https://www.biotechsnap.com/p/agomab-and-spyglass-top-a-1b-ipo-week-bayer-wins-a-blood-thinner-trial 2026-02-09 1.0 https://www.biotechsnap.com/p/cartography-bioscience-t-cell-engager-fundraising 2025-10-06 1.0 https://www.biotechsnap.com/p/editas-high-cholesterol-gene-editing 2025-09-03 1.0 https://www.biotechsnap.com/p/daily-snap-30-october-2025 2025-10-30 1.0 https://www.biotechsnap.com/p/merck-skyhawk-brain-diseases-deal 2025-08-19 1.0 https://www.biotechsnap.com/p/abbvie-strikes-5-6b-oncology-deal-with-china-s-remegen-at-jpm26-novartis-bets-1-7b-on-scineuro-s-bra 2026-01-13 1.0 https://www.biotechsnap.com/p/novartis-tourmaline-buyout 2025-09-10 1.0 https://www.biotechsnap.com/p/roche-breast-cancer-giredestrant-combo-trial 2025-10-20 1.0 https://www.biotechsnap.com/p/gilead-acquires-ouro-for-1-7b-merck-pays-quotient-20-million-for-new-ibd-drugs 2026-03-25 1.0 https://www.biotechsnap.com/p/enveda-nature-based-drug-pipeline-fundraising 2025-09-05 1.0 https://www.biotechsnap.com/p/eli-lilly-superluminal-gpcr-obesity 2025-08-15 1.0 https://www.biotechsnap.com/p/fda-approval-insmed-brinsupri-dpp1 2025-08-13 1.0 https://www.biotechsnap.com/p/openai-chai-discovery-fundraising 2025-08-07 1.0 https://www.biotechsnap.com/p/axsome-acquisition-astrazeneca-epilepsy-drug 2025-11-07 1.0 https://www.biotechsnap.com/p/zymeworks-pivots-royalty-model-ziihera 2025-11-19 1.0 https://www.biotechsnap.com/p/daily-snap-2-september-2025 2025-09-02 1.0 https://www.biotechsnap.com/p/xoma-acquisition-hillevax-lava-therapeutics 2025-08-05 1.0 https://www.biotechsnap.com/p/daily-snap-15-september-2025 2025-09-15 1.0 https://www.biotechsnap.com/p/eikon-makes-a-381m-ipo-debut-angitia-raises-130m-for-dual-action-bone-builders 2026-02-06 1.0 https://www.biotechsnap.com/p/amgen-taps-into-disco-pharma-s-pipeline-gsk-ionis-have-a-functional-cure-for-hepatitis-b 2026-01-08 1.0 https://www.biotechsnap.com/p/novartis-phase-3-sjogren-syndrome 2025-08-12 1.0 https://www.biotechsnap.com/p/solve-therapeutics-adc-fundraising 2025-11-18 1.0 https://www.biotechsnap.com/p/galapagos-cell-therapy-sale 2025-10-06 1.0 https://www.biotechsnap.com/p/daily-snap-21-november-2025 2025-11-21 1.0 https://www.biotechsnap.com/p/daily-snap-15-october-2025 2025-10-15 1.0 https://www.biotechsnap.com/p/china-biotech-deal-value-2025 2025-07-15 1.0 https://www.biotechsnap.com/p/daily-snap-12-november-2025 2025-11-12 1.0 https://www.biotechsnap.com/p/pfizer-s-parp-inhibitor-scores-clinical-win-lilly-s-triple-agonist-diabetes-drug-shows-positive-phas 2026-03-23 1.0 https://www.biotechsnap.com/p/sarepta-cut-workforce-gene-therapy-setback 2025-07-17 1.0 https://www.biotechsnap.com/p/trump-fda-expert-drug-reviews 2025-09-15 1.0 https://www.biotechsnap.com/p/the-first-stem-cell-therapy-for-epilepsy-enters-human-testing-sana-s-islet-cell-therapy-maintains-in 2026-03-17 1.0 https://www.biotechsnap.com/p/angelini-sovergen-brain-deal 2025-09-23 1.0 https://www.biotechsnap.com/p/astrazeneca-acquisition-sixpeaks-versant-weight-loss 2025-11-10 1.0 https://www.biotechsnap.com/p/regeneron-db-oto-gene-therapy-hearing-children 2025-10-14 1.0 https://www.biotechsnap.com/p/sanofi-wins-in-gaucher-disease-gsk-abandons-a-pioneering-rna-editing-drug 2026-02-03 1.0 https://www.biotechsnap.com/p/lilly-gene-therapy-meiragtx-deal-leber-congenital-amaurosis-4 2025-11-11 1.0 https://www.biotechsnap.com/p/daily-snap-29-october-2025 2025-10-29 1.0 https://www.biotechsnap.com/p/star-therapeutics-phase-1-2-win-in-bleeding-disorder 2025-12-08 1.0 https://www.biotechsnap.com/p/astrazeneca-signs-a-massive-18b-obesity-deal-a-bunch-of-pharmas-clean-their-pipeline 2026-02-02 1.0 https://www.biotechsnap.com/p/abbvie-trispecific-antibody-ichnos-glenmark 2025-07-10 1.0 https://www.biotechsnap.com/p/daily-snap-19-august-2025 2025-08-19 1.0 https://www.biotechsnap.com/p/roche-mash-89bio-acquisition 2025-09-19 1.0 https://www.biotechsnap.com/p/abbvie-psychedelic-gilgamesh-acquisition 2025-08-26 1.0 https://www.biotechsnap.com/p/enodia-snaps-up-competitor-s-pipeline-for-127m-ultragenyx-aav-based-gene-therapy-strikes-a-win-in-ph-a952 2026-03-16 1.0 https://www.biotechsnap.com/p/generate-biomedicines-raises-400m-in-ipo-atrium-therapeutics-launches-with-270m-and-two-sirna-drugs- 2026-03-03 1.0 https://www.biotechsnap.com/p/fosun-deal-sitala 2025-08-27 1.0 https://www.biotechsnap.com/p/merck-hiv-blockbuster-trial 2025-11-20 1.0 https://www.biotechsnap.com/p/daily-snap-25-august-2025 2025-08-26 1.0 https://www.biotechsnap.com/p/lilly-snaps-up-in-vivo-car-t-specialist-orna-for-2-4b-signs-a-8-5b-deal-with-china-based-innovent 2026-02-10 1.0 https://www.biotechsnap.com/p/migraine-focused-slate-medicines-launches-with-130m-gsk-s-1b-deal-for-two-sirna-oligonucleotides 2026-02-25 1.0 https://www.biotechsnap.com/p/novartis-fda-approval-rhapsido-btk-chronic-hives 2025-10-02 1.0 https://www.biotechsnap.com/p/evommune-and-nektar-show-stellar-data-in-eczema-the-fda-rejects-regenxbio-s-gene-therapy 2026-02-11 1.0 https://www.biotechsnap.com/p/crescent-s-adc-deal-with-kelun-pharvaris-phase-3-win-in-hereditary-angioedema 2025-12-09 1.0 https://www.biotechsnap.com/p/repertoire-signs-a-1-9b-autoimmune-disorders-deal-sanofi-cleans-its-pipeline 2026-01-30 1.0 https://www.biotechsnap.com/p/versant-dayra-biogen-deal-oral-macrocyclic-peptide 2025-11-25 1.0 https://www.biotechsnap.com/p/takeda-oncology-deal-innovent-china-biotech 2025-10-23 1.0 https://www.biotechsnap.com/p/aditum-bio-sirna-kalexo-mabwell 2025-09-18 1.0 https://www.biotechsnap.com/p/aviadobio-eye-diseases-ugenex-deal 2025-10-10 1.0 https://www.biotechsnap.com/p/daily-snap-13-november-2025 2025-11-13 1.0 https://www.biotechsnap.com/p/daily-snap-14-october-2025 2025-10-14 1.0 https://www.biotechsnap.com/p/lily-buys-ventyx-for-1-2b-epibiologics-raises-107m-for-its-protein-degraders 2026-01-09 1.0 https://www.biotechsnap.com/p/trump-crackdown-us-china-deals 2025-09-11 1.0 https://www.biotechsnap.com/p/strand-therapeutics-series-b 2025-08-08 1.0 https://www.biotechsnap.com/p/merck-enlicitide-oral-cholesterol-pill 2025-11-12 1.0 https://www.biotechsnap.com/p/novo-nordisk-pfizer-obesity-glp1-metsera 2025-10-31 1.0 https://www.biotechsnap.com/p/bayer-bluerock-cuts-staff 2025-06-26 1.0 https://www.biotechsnap.com/p/daily-snap-18-august-2025 2025-08-18 1.0 https://www.biotechsnap.com/p/daily-snap-10-october-2025 2025-10-10 1.0 https://www.biotechsnap.com/p/daily-snap-17-september-2025 2025-09-17 1.0 https://www.biotechsnap.com/p/daily-snap-18-september-2025 2025-09-18 1.0 https://www.biotechsnap.com/p/daily-snap-27-august-2025 2025-08-27 1.0 https://www.biotechsnap.com/p/next-gen-jak-inhibitor-wins-phase-3-in-eczema-uniqure-s-shares-fell-more-than-40-after-fda-rejection 2026-03-04 1.0 https://www.biotechsnap.com/p/vor-pivot-autoimmune-disease 2025-06-27 1.0 https://www.biotechsnap.com/p/innovacell-wants-to-revive-tokyo-s-biotech-ipos-compass-psychedelics-success-in-phase-3-for-depressi 2026-02-18 1.0 https://www.biotechsnap.com/p/merck-evaxion-ai-vaccine-deal 2025-09-26 1.0 https://www.biotechsnap.com/p/maplight-ipo-schizophrenia-drug 2025-10-08 1.0 https://www.biotechsnap.com/p/lb-pharma-ipo-schizophrenia 2025-08-26 1.0 https://www.biotechsnap.com/p/actithera-series-a-radiopharma 2025-07-10 1.0 https://www.biotechsnap.com/p/daily-snap-22-september-2025 2025-09-22 1.0 https://www.biotechsnap.com/p/gsk-empirico-copd-deal 2025-10-29 1.0 https://www.biotechsnap.com/p/nxera-obesity-drugs-pfizer-novo-terns-exit-glp-1 2025-08-07 1.0 https://www.biotechsnap.com/p/vertex-cure-type-1-diabetes-stem-cells 2025-06-23 1.0 https://www.biotechsnap.com/p/contineum-multiple-sclerosis-drug-phase-2 2025-11-24 1.0 https://www.biotechsnap.com/p/flagship-pioneering-ai-startup-expedition-medicines 2025-10-23 1.0 https://www.biotechsnap.com/p/sanofi-amlitelimab-eczema-trial 2025-09-05 1.0 https://www.biotechsnap.com/p/pfizer-mrna-flu-shot-sanofi-fluzone-trial 2025-11-21 1.0 https://www.biotechsnap.com/p/fda-at-home-leqembi-alzheimer 2025-09-01 1.0 https://www.biotechsnap.com/p/gilead-interius-acquisition 2025-08-22 1.0 https://www.biotechsnap.com/p/janux-s-t-cell-therapy-misses-the-mark 2025-12-03 1.0 https://www.biotechsnap.com/p/xtalpi-dovetree-ai-partnering 2025-08-08 1.0 https://www.biotechsnap.com/p/daily-snap-12-august-2025 2025-08-12 1.0 https://www.biotechsnap.com/p/gilead-acquires-arcellx-s-cell-therapy-for-7-8b-generate-biomedicines-plans-425-million-ipo 2026-02-24 1.0 https://www.biotechsnap.com/p/novartis-acquisition-avidity-rna-drug-muscle-disease 2025-10-28 1.0 https://www.biotechsnap.com/p/novo-nordisk-alzheimer-glp1-trials 2025-11-25 1.0 https://www.biotechsnap.com/p/daily-snap-7-november-2025 2025-11-07 1.0 https://www.biotechsnap.com/p/ac-immune-s-promising-parkinson-s-vaccine-a-british-biotech-buys-a-us-company-for-pennies-per-share- 2025-12-16 1.0 https://www.biotechsnap.com/p/daily-snap-25-september-2025 2025-09-25 1.0 https://www.biotechsnap.com/p/r1-therapeutics-raises-78m-for-its-kidney-disease-drug-cytomx-s-shares-surge-over-60-after-phase-1-r 2026-03-18 1.0 https://www.biotechsnap.com/p/the-race-for-the-next-obesity-blockbuster-intensifies-as-novo-pfizer-and-skye-share-results 2026-02-04 1.0 https://www.biotechsnap.com/p/merck-msd-blackrock-adc-sacituzumab-tirumotecan 2025-11-06 1.0 https://www.biotechsnap.com/p/belite-bio-s-phase-3-success-in-stargardt 2025-12-02 1.0 https://www.biotechsnap.com/p/regeneron-modex-antibody-deal 2025-10-30 1.0 https://www.biotechsnap.com/p/daily-snap-29-august-2025 2025-08-29 1.0 https://www.biotechsnap.com/p/sanofi-ventures-new-fund-biotech 2025-09-25 1.0 https://www.biotechsnap.com/p/io-biotech-skin-cancer-vaccine-miss 2025-08-12 1.0 https://www.biotechsnap.com/p/uk-life-sciences-abpi-investment-report 2025-09-11 1.0 https://www.biotechsnap.com/p/aspen-series-c-parkinson 2025-11-21 1.0 https://www.biotechsnap.com/p/daily-snap-8-october-2025 2025-10-08 1.0 https://www.biotechsnap.com/p/pinnacle-raises-89m-for-its-oral-peptide-drugs-beam-reports-positive-phase-1-2-trial-of-its-base-edi 2026-03-27 1.0 https://www.biotechsnap.com/p/seamless-signs-1-1b-eli-lilly-gene-therapy-deal-to-tune-up-hearing-boehringer-advances-kidney-drug-i 2026-01-29 1.0 https://www.biotechsnap.com/p/caldera-raised-112m-to-target-ibd-cyprium-s-menkes-disease-drug-get-approved 2026-01-15 1.0 https://www.biotechsnap.com/p/arkbio-s-antiviral-ziresovir-who-list 2025-07-16 1.0 https://www.biotechsnap.com/p/capricor-s-duchenne-comeback-triana-s-120m-molecular-glue-degrader 2025-12-04 1.0 https://www.biotechsnap.com/p/daily-snap-14-july-2025 2025-07-16 1.0 https://www.biotechsnap.com/p/4dmt-otsuka-deal-retinal-gene-therapy 2025-11-03 1.0 https://www.biotechsnap.com/p/fda-approval-ionis-dawnzera 2025-08-22 1.0 https://www.biotechsnap.com/p/fda-fast-track-biosimilar 2025-10-31 1.0 https://www.biotechsnap.com/p/daily-snap-19-november-2025 2025-11-19 1.0 https://www.biotechsnap.com/p/daily-snap-20-november-2025 2025-11-20 1.0 https://www.biotechsnap.com/p/alfasigma-bets-up-to-690m-on-gsk-s-pbc-itch-drug-roche-s-breast-cancer-drug-fails-phase-3 2026-03-10 1.0 https://www.biotechsnap.com/p/star-therapeutics-bleeding-disorder-series-d 2025-10-01 1.0 https://www.biotechsnap.com/p/daily-snap-19-september-2025 2025-09-19 1.0 https://www.biotechsnap.com/p/daily-snap-16-september-2025 2025-09-16 1.0 https://www.biotechsnap.com/p/celldex-eosinophilic-esophagitis-trial-failure 2025-08-21 1.0 https://www.biotechsnap.com/p/daily-snap-26-november-2025 2025-11-26 1.0 https://www.biotechsnap.com/p/novartis-monte-rosa-protein-degrading-drugs 2025-09-16 1.0 https://www.biotechsnap.com/p/funding-cuts-mrna-vaccine-investment 2025-10-07 1.0 https://www.biotechsnap.com/p/concentra-acquisition-cargo-therapeutics 2025-07-09 1.0 https://www.biotechsnap.com/p/halda-deal-vantai-riptac 2025-08-20 1.0 https://www.biotechsnap.com/p/bms-in-vivo-car-t-orbital-therapeutics-acquisition 2025-10-13 1.0 https://www.biotechsnap.com/p/daily-snap-18-november-2025 2025-11-18 1.0 https://www.biotechsnap.com/p/maat-pharma-clinigen-partnership 2025-07-04 1.0 https://www.biotechsnap.com/p/biogen-immune-drug-vanqua-bio-deal 2025-10-27 1.0 https://www.biotechsnap.com/p/novo-nordisk-acquisition-akero-mash-drug 2025-10-10 1.0 https://www.biotechsnap.com/p/daily-snap-16-october-2025 2025-10-16 1.0 https://www.biotechsnap.com/p/daily-snap-22-august-2025 2025-08-22 1.0 https://www.biotechsnap.com/p/corvus-stock-explodes-on-eczema-pill-results-corxel-raises-287-million-for-its-oral-glp-1 2026-01-23 1.0 https://www.biotechsnap.com/p/chiesi-arbor-gene-therapy-kidney-disease 2025-10-07 1.0 https://www.biotechsnap.com/p/blackstone-raises-record-6-3b-life-sciences-fund-lilly-acquires-centessa-for-6-3b 2026-04-01 1.0 https://www.biotechsnap.com/p/lilly-breaks-records-with-29-weight-loss-zealand-inks-2-5b-deal-with-china-s-otr 2025-12-12 1.0 https://www.biotechsnap.com/p/crystalys-launch-gout-drug 2025-10-01 1.0 https://www.biotechsnap.com/p/daily-snap-7-october-2025 2025-10-07 1.0 https://www.biotechsnap.com/p/calico-mabwell-il-11-antibody 2025-06-30 1.0 https://www.biotechsnap.com/p/daily-snap-14-november-2025 2025-11-14 1.0 https://www.biotechsnap.com/p/zenas-drug-trial-success-fails-to-impress-wall-street-shares-crash-55 2026-01-06 1.0 https://www.biotechsnap.com/p/daily-snap-23-september-2025 2025-09-23 1.0 https://www.biotechsnap.com/p/pfizer-signs-a-530m-vaccine-deal-novo-drops-another-cell-therapy 2026-01-22 1.0 https://www.biotechsnap.com/p/daily-snap-15-august-2025 2025-08-15 1.0 https://www.biotechsnap.com/p/pfizer-pd1-vegf-bispecific-trials 2025-11-13 1.0 https://www.biotechsnap.com/p/novartis-rnai-argo-deal 2025-09-04 1.0 https://www.biotechsnap.com/p/gilead-trex1-cancer-drug-sprint-bioscience 2025-11-26 1.0 https://www.biotechsnap.com/p/lyell-car-t-colorectal-cancer 2025-11-11 1.0 https://www.biotechsnap.com/p/nrg-therapeutics-series-b-parkinson-als-mitochondria 2025-09-09 1.0 https://www.biotechsnap.com/p/daily-snap-22-october-2025 2025-10-22 1.0 https://www.biotechsnap.com/p/fda-rejection-capricor-duchenne 2025-07-14 1.0 https://www.biotechsnap.com/p/the-first-new-motion-sickness-drug-since-1979-genmab-s-pipeline-update 2026-01-05 1.0 https://www.biotechsnap.com/p/innovacell-wants-to-revive-tokyo-s-biotech-ipos-compass-psychedelics-success-in-phase-3-for-depressi-4ce5 2026-02-19 1.0 https://www.biotechsnap.com/p/daily-snap-1-september-2025 2025-09-01 1.0 https://www.biotechsnap.com/p/daily-snap-2-october-2025 2025-10-02 1.0 https://www.biotechsnap.com/p/moonlake-sonelokimab-failure 2025-09-30 1.0 https://www.biotechsnap.com/p/evaxion-melanoma-vaccine-trial 2025-10-20 1.0 https://www.biotechsnap.com/p/bayer-kumquat-kras-inhibitor-cancer-drug 2025-08-13 1.0 https://www.biotechsnap.com/p/daily-snap-11-september-2025 2025-09-11 1.0 https://www.biotechsnap.com/p/the-weight-loss-industry-has-a-new-winner-a-hair-loss-company-raises-256-3m-in-an-ipo 2026-02-05 1.0 https://www.biotechsnap.com/p/amgen-buys-dark-blue-s-protein-degraders-alumis-psoriasis-pill-shows-big-promise 2026-01-07 1.0 https://www.biotechsnap.com/p/madrigal-touts-breakout-year-in-mash-candel-secures-100m-for-its-prostate-cancer-therapy 2026-02-23 1.0 https://www.biotechsnap.com/p/daily-snap-24-november-2025 2025-11-24 1.0 https://www.biotechsnap.com/p/novartis-arrowhead-rna-parkinson 2025-09-03 1.0 https://www.biotechsnap.com/p/lundbeck-alkermes-avadel-bidding-war 2025-11-17 1.0 https://www.biotechsnap.com/p/daily-snap-6-november-2025 2025-11-06 1.0 https://www.biotechsnap.com/p/fda-noninvasive-liver-biomarker-mash 2025-08-29 1.0 https://www.biotechsnap.com/p/biotech-job-cuts-pacira-karyopharm-century 2025-07-14 1.0 https://www.biotechsnap.com/p/takeda-s-4b-psoriasis-pill-shows-blockbuster-promise-in-major-trials-viaskin-patch-phase-3-win-puts 2025-12-19 1.0 https://www.biotechsnap.com/p/terns-new-data-challenges-novartis-pfizer-buys-a-chinese-obesity-pill 2025-12-10 1.0 https://www.biotechsnap.com/p/novartis-malaria-drug-ganaplacide-lumefantrine 2025-11-14 1.0 https://www.biotechsnap.com/p/roche-breast-cancer-oral-serd-race 2025-11-19 1.0 https://www.biotechsnap.com/p/fda-rare-disease-drug-pathway 2025-09-04 1.0 https://www.biotechsnap.com/p/sanofi-re-enter-t-cell-engager-space-1-2b-on-early-stage-trispecific-antibody-to-re-enter-hot-t-cell 2026-03-24 1.0 https://www.biotechsnap.com/p/daily-snap-11-november-2025 2025-11-11 1.0 https://www.biotechsnap.com/p/revolution-daraxonrasib-pdac-trial 2025-09-12 1.0 https://www.biotechsnap.com/p/d3-bio-lands-108m-for-its-kras-cancer-drug-formation-bio-launches-a-startup-with-a-605m-deal 2025-12-11 1.0 https://www.biotechsnap.com/p/daily-snap-1-october-2025 2025-10-01 1.0 https://www.biotechsnap.com/p/gilead-signs-a-1-5b-deal-for-genhouse-bio-s-oral-cancer-drug-the-fda-rejects-disc-medicine-s-rare-di 2026-02-17 1.0 https://www.biotechsnap.com/p/vima-raises-100m-series-a-cns-pharma-abandons-its-glioblastoma-pipeline 2026-03-12 1.0 https://www.biotechsnap.com/p/biokin-phase-3-bispecific-adc 2025-07-03 1.0 https://www.biotechsnap.com/p/daily-snap-6-october-2025 2025-10-06 1.0 https://www.biotechsnap.com/p/daily-snap-3-september-2025 2025-09-03 1.0 https://www.biotechsnap.com/p/astrazeneca-esobiotec-in-vivo-car-t-trial 2025-07-08 1.0 https://www.biotechsnap.com/p/vor-sjoegren-trial-success 2025-08-14 1.0 https://www.biotechsnap.com/p/kailera-obesity-drug-fundraising 2025-10-15 1.0 https://www.biotechsnap.com/p/jazz-saniona-epilepsy 2025-08-21 1.0 https://www.biotechsnap.com/p/gilead-mash-exit 2025-08-11 1.0 https://www.biotechsnap.com/p/bridgebio-encaleret-adh1-2025-trial-rare-endocrine-disorder 2025-10-30 1.0 https://www.biotechsnap.com/p/precigen-recurrent-respiratory-papillomatosis-approval 2025-08-18 1.0 https://www.biotechsnap.com/p/daily-snap-5-august-2025 2025-08-05 1.0 https://www.biotechsnap.com/p/prokidney-cell-therapy-chronic-kidney-disease-trial 2025-07-09 1.0 https://www.biotechsnap.com/p/fda-rems-car-t-cancer-therapies 2025-06-30 1.0 https://www.biotechsnap.com/p/korsana-s-alzheimer-s-antibody-launches-with-175m-novartis-signs-a-1-7b-deal-with-unnatural-products 2026-02-20 1.0 https://www.biotechsnap.com/p/daily-snap-3-november-2025 2025-11-03 1.0 https://www.biotechsnap.com/p/daily-snap-24-september-2025 2025-09-24 1.0 https://www.biotechsnap.com/p/novo-nordisk-rna-deal-replicate 2025-08-29 1.0 https://www.biotechsnap.com/p/daily-snap-12-september-2025 2025-09-12 1.0 https://www.biotechsnap.com/p/daily-snap-20-october-2025 2025-10-20 1.0 https://www.biotechsnap.com/p/tubulis-record-series-c-adc 2025-10-16 1.0 https://www.biotechsnap.com/p/spyglass-and-agomab-plan-an-ipo-genmab-fails-a-phase-3 2026-01-20 1.0 https://www.biotechsnap.com/p/elamipretide-fda-approval-barth-syndrome 2025-09-22 1.0 https://www.biotechsnap.com/p/daily-snap-30-september-2025 2025-09-30 1.0 https://www.biotechsnap.com/p/vyne-bet-inhibitor-psoriasis 2025-07-03 1.0 https://www.biotechsnap.com/p/yarrow-buys-a-chinese-thyroid-drug-for-1-37b-aviceda-s-lead-eye-drug-misses-key-trial 2025-12-17 1.0 https://www.biotechsnap.com/p/bridgebio-s-dwarfism-pill-delivers-standout-phase-3-data-the-first-approval-of-an-immune-checkpoint- 2026-02-16 1.0 https://www.biotechsnap.com/p/praxis-tremor-drug-success 2025-10-17 1.0 https://www.biotechsnap.com/p/daily-snap-13-october-2025 2025-10-13 1.0 https://www.biotechsnap.com/p/hemab-fundraising-rare-blood-disorder 2025-10-28 1.0 https://www.biotechsnap.com/p/wugen-off-the-shelf-car-t-cancers 2025-08-28 1.0 https://www.biotechsnap.com/p/eli-lilly-san-diego-incubator 2025-09-29 1.0 https://www.biotechsnap.com/p/alkermes-alixorexton-narcolepsy-trial 2025-11-13 1.0 https://www.biotechsnap.com/p/amgen-phase-3-gastric-cancer-trial 2025-07-01 1.0 https://www.biotechsnap.com/p/genmab-adc-profoundbio-safety-gen1107 2025-09-17 1.0 https://www.biotechsnap.com/p/novo-nordisk-weekly-diabetes-combo-kyinsu 2025-09-22 1.0 https://www.biotechsnap.com/p/lila-ai-scientific-superintelligence-labs 2025-09-16 1.0 https://www.biotechsnap.com/p/daily-snap-10-september-2025 2025-09-10 1.0 https://www.biotechsnap.com/p/lexeo-rna-heart-drug-spinout 2025-06-25 1.0 https://www.biotechsnap.com/p/mirum-s-620m-acquisition-of-bluejay-biontech-s-ctla-4-safety-trade-offs 2025-12-09 1.0 https://www.biotechsnap.com/p/otsuka-cantargia-antibody-deal 2025-07-17 1.0 https://www.biotechsnap.com/p/fda-leucovorin-gsk-autism 2025-09-24 1.0 https://www.biotechsnap.com/p/two-next-gen-t-cell-engager-companies-raised-a-combined-146m-aspen-shows-promising-early-results-in 2026-03-20 1.0 https://www.biotechsnap.com/p/galimedix-phase-2-alzheimer-oral-drug 2025-09-15 1.0 https://www.biotechsnap.com/p/summit-ivonescimab-lung-cancer-drug-skepticism 2025-10-21 1.0 https://www.biotechsnap.com/p/daily-snap-21-august-2025 2025-08-22 1.0 https://www.biotechsnap.com/p/lilly-versanis-muscle-sparing-obesity-drug-trial-halt 2025-09-26 1.0 https://www.biotechsnap.com/p/daily-snap-10-november-2025 2025-11-10 1.0 https://www.biotechsnap.com/p/cogent-trial-data-bezuclastinib-systemic-mastocytosis 2025-07-08 1.0 https://www.biotechsnap.com/p/merck-acquisition-verona-pharma 2025-07-09 1.0 https://www.biotechsnap.com/p/compass-psilocybin-trial-stock-down 2025-06-24 1.0 https://www.biotechsnap.com/p/fda-rejection-scholar-rock-spinal-muscular-atrophy-apitegromab 2025-09-24 1.0 https://www.biotechsnap.com/p/biocryst-acquisition-astria 2025-10-15 1.0 https://www.biotechsnap.com/p/neurocrine-depression-drug-fails-trial 2025-11-12 1.0 https://www.biotechsnap.com/p/merck-bets-6-7b-on-terns-sarepta-shows-strong-rnai-clinical-results 2026-03-26 1.0 https://www.biotechsnap.com/p/vectory-brain-gene-therapy-shape-delivery 2025-09-19 1.0 https://www.biotechsnap.com/p/asahi-kasei-s-buys-germany-s-aicuris-for-920m-boehringer-signs-a-500m-deal-with-uk-based-sitryx 2026-02-27 1.0 https://www.biotechsnap.com/p/zag-bio-launch-autoimmune-diseases 2025-10-29 1.0 https://www.biotechsnap.com/p/arrowhead-fda-approval-redemplo-familial-chylomicronemia-syndrome 2025-11-20 1.0 https://www.biotechsnap.com/p/pdl1-vegf-bispecifics-ivonescimab-survival-akeso-summit 2025-11-10 1.0 https://www.biotechsnap.com/p/argenx-unnatural-products-oral-peptide 2025-07-02 1.0 https://www.biotechsnap.com/p/regeneron-cemdisiran-phase-3-sirna-myasthenia-gravis 2025-08-27 1.0 https://www.biotechsnap.com/p/biogen-exit-aav-gene-therapy 2025-09-29 1.0 https://www.biotechsnap.com/p/ollin-biosciences-vabysmo-roche-eye-disease 2025-09-18 1.0 https://www.biotechsnap.com/p/braveheart-bio-launch-fundraising-heart-drug 2025-11-06 1.0 https://www.biotechsnap.com/p/hhs-stop-barda-mrna-vaccine 2025-08-06 1.0 https://www.biotechsnap.com/p/cidara-flu-drug-results 2025-06-24 1.0 https://www.biotechsnap.com/p/wegovy-heart-risk-over-zepbound 2025-09-02 1.0 https://www.biotechsnap.com/p/daily-snap-13-august-2025 2025-08-15 1.0 https://www.biotechsnap.com/p/abbvie-capstan-acquisition 2025-07-01 1.0 https://www.biotechsnap.com/p/praxis-epilepsy-phase-2-vormatrigine 2025-08-05 1.0 https://www.biotechsnap.com/p/ramaswamy-s-ambros-launches-with-125m-to-target-chronic-pain-without-opioids-eu-launches-biotech-act 2025-12-18 1.0 https://www.biotechsnap.com/p/daily-snap-20-august-2025 2025-08-20 1.0 https://www.biotechsnap.com/p/alnylam-and-tenaya-sign-1b-heart-disease-deal-atavistik-raises-160m-to-advance-rare-blood-disorders 2026-03-06 1.0 https://www.biotechsnap.com/p/roche-ai-brain-manifold 2025-11-04 1.0 https://www.biotechsnap.com/p/daily-snap-8-august-2025 2025-08-08 1.0 https://www.biotechsnap.com/p/sanofi-radioligand-phase-2 2025-10-09 1.0 https://www.biotechsnap.com/p/fortitude-launches-to-combine-adcs-with-protein-degraders-sanofi-takes-a-gamble-with-eczema 2026-01-27 1.0 https://www.biotechsnap.com/p/daily-snap-28-august-2025 2025-08-28 1.0 https://www.biotechsnap.com/p/daily-snap-5-september-2025 2025-09-05 1.0 https://www.biotechsnap.com/p/biopharma-2024-slowdown-massachusetts-boston 2025-08-28 1.0